US 10369201
Methods and compositions for treating Huntington's disease
granted A61KA61K38/10A61K38/164
Quick answer
US patent 10369201 (Methods and compositions for treating Huntington's disease) held by Sangamo Therapeutics, Inc. expires Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Therapeutics, Inc.
- Grant date
- Tue Aug 06 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 01 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 9
- CPC classes
- A61K, A61K38/10, A61K38/164, A61K38/465, A61K48/00